Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2

The ongoing pandemic of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health. Drug repurposing is a time-efficient approach to finding effective drugs against SARS-CoV-2 in this emergency. Here, we present a robust experimental design combining deep learning with mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Anwaar, Muhammad U., Adnan, Farjad, Abro, Asma, Khan, Rayyan A., Rehman, Asad U., Osama, Muhammad, Rainville, Christopher, Kumar, Suresh, Sterner, David E., Javed, Saad, Jamal, Syed B., Baig, Ahmadullah, Shabbir, Muhammad R., Ahsan, Waseh, Butt, Tauseef R., Assir, Muhammad Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604796/
https://www.ncbi.nlm.nih.gov/pubmed/34823857
http://dx.doi.org/10.1016/j.compbiomed.2021.105049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604796/
https://www.ncbi.nlm.nih.gov/pubmed/34823857
http://dx.doi.org/10.1016/j.compbiomed.2021.105049

Ejemplares similares